Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: sds who wrote (1920)	4/9/1998 4:25:00 PM
From: marc ultra	Read Replies (1) \| Respond to of 4676

While I am not an expert on FDA thinking I would think this will get relatively rapid consideration. We are talking here about stopping blindness in AIDS patients and the AIDS lobby was a big factor in getting rapid approvals and the FDA is sensitive to moving on any AIDS related drugs. I don't think they will take the attitude that hey this is only blindness not death so we can twiddle our thumbs for a year. On the other hand there may be some with concerns about antisense in general that may want to hash out some issues